MARKET

ABT

ABT

Abbott Labs
NYSE
105.24
-0.72
-0.68%
After Hours: 100.00 -5.24 -4.98% 19:59 07/26 EDT
OPEN
106.46
PREV CLOSE
105.96
HIGH
107.14
LOW
104.66
VOLUME
8.61M
TURNOVER
0
52 WEEK HIGH
121.64
52 WEEK LOW
88.33
MARKET CAP
183.08B
P/E (TTM)
33.11
1D
5D
1M
3M
1Y
5Y
1D
Abbott Ordered to Pay $495 Million in Baby-Formula Verdict
The Wall Street Journal · 32m ago
Notable Friday Option Activity: RMD, GM, ABT
NASDAQ · 2h ago
Abbott Labs falls after jury awards plaintiff $95M in damages in baby formula case
Abbott Labs falls after jury awards plaintiff $95M in damages in baby formula case. Illinois resident Margo Gill sued Abbott alleging her premature baby girl developed necrotizing enterocolitis and suffered brain damage after being fed the company's formula. Abbott and Reckitt Benckiser's Mead Johnson face more than 1,000 similar lawsuits.
Seeking Alpha · 2h ago
DexCom reaches a multi-year low as downgrades follow guidance cut
Seeking Alpha · 6h ago
Integer Holdings (ITGR) Q2 Earnings Top Estimates, Margins Up
NASDAQ · 9h ago
Peering Into Abbott Laboratories's Recent Short Interest
Abbott Laboratories's short percent of float has fallen 17.33% since its last report. The company has 10.75 million shares sold short, which is 0.62% of all regular shares available for trading. Short interest is the number of shares that have been sold short but have not yet been covered.
Benzinga · 11h ago
Dexcom (DXCM) Stock Is Plunging on an ‘Execution Miss.’ What Is Really Going On?
Dexcom (NASDAQ:DXCM) stock is down over 40% after reporting disappointing revenue for the second quarter. The company lowered guidance for the rest of the year and delayed the launch of its Stelo continuous glucose monitor. Stelo monitors deliver data to the Apple Watch or other devices via Bluetooth.
Investorplace · 11h ago
Amedisys (AMED) Q2 Earnings Top Estimates, Gross Margin Down
NASDAQ · 14h ago
More
About ABT
Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.

Webull offers Abbott Laboratories stock information, including NYSE: ABT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABT stock methods without spending real money on the virtual paper trading platform.